Guidelines on prevention and treatment of vitamin D deficiency;Linee guida su prevenzione e trattamento dell'ipovitaminosi D con colecalciferolo

Reumatismo

Volumn 63, Issue 3, 2011, Pages 129-147

  Adami, S ^a   Romagnoli, E ^b   Carnevale, V ^b   Scillitani, A ^c   Giusti, A ^d   Rossini, M ^a   Gatti, D ^a   Nuti, R ^d   Minisola, S ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Ospedale S Giovanni Rotondo   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; VITAMIN D;

AGING; ARTICLE; CALCIUM INTAKE; DOSE RESPONSE; GRANULOMATOSIS; HUMAN; HYPERTHYROIDISM; ITALY; PATIENT ASSESSMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANT WOMAN; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 80855129604     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2011.129     Document Type: Article

References (126)

1. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002; 9: 87-98.
2. Holick MF. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ, Editor. Primeron the metabolic bone diseases and disorders of mineral metabolism. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 1999: 92-98.
3. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet radiation. Lancet 1989; 2: 1104-5.
4. Maggio D, Cherubini A, Lauretani F, Russo RC, Bartali B, Pierandrei M, et al. 25(OH) D serum levels decline with age earlier in women than in men and less efficiently prevent compensatory hyperparathyroidism in older adults. J Gerontol A Biol Sci Med Sci 2005; 60: 1414-9.
5. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990; 51: 1075-81.
6. Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010; 51: 1158-67.
7. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 981-91.
8. Smith JE, Goodman DS. The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest 1971; 50: 2159-67.
9. Haddad JG, Rojanasathit S. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab 1976; 42: 284-90.
10. Russo S, Carlucci L, Cipriani C, Ragno A, Piemonte S, Del Fiacco R, et al. Metabolic changes following 500 mcg monthly administration of calcidiol: a study in normal females. Calcif Tissue Int 2011; 89: 252-7.
11. Jones G. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial 2010; 23: 239-43.
12. Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC. 1,25(OH)2D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992; 41: 231-40.
13. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976; 1: 626-7.
14. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 7: 434-48.'
15. Mowè M, Haug E, Bøhmer T. Low serum calcidiol concentration in older adults with reduced muscolar function. J Am Geriatr So c 1999; 47: 220-6.
16. Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999; 80: 54-8.
17. Pfeifer M, Begerow B, Minne HW, Schlotthauer T, Pospeschill M, Scholz M, et al. Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 2001; 109: 87-92.
18. Zamboni M, Zoico E, Tosoni P, Zivelonghi A, Bortolani A, Maggi S, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci 2002; 57: M7-11.
19. Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SH, Swift CG, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002; 17: 891-7.
20. Visser M, Deeg DJ, Lips P. Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88: 5766-72.
21. Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ 2005; 330: 524-6.
22. Gerdhem P, Ringsberg KAM, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 2005; 16: 1425-31.
23. Houston DK, Cesari M, Ferrucci L, Cherubini A, Maggio D, Bartali B, et al. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2007; 62: 440-6.
24. Summary of the Updated American Geriatric Society/ British Geriatrics Society Clinical Practice Guidelines for Prevention of Falls in Older Persons. J Am Geriatr Soc 2011; 59: 148-57.
25. Yoshikawa S, Nakamura T, Tanabe H, Imamura T. Osteomalacic myopathy. Endocrinol Jpn 1979; 26: 65-72.
26. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18: 343-51.
27. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et al. Effect of vitamin D on falls. JAMA 2004; 291: 1999-2006.
28. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692.
29. Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm TN, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004; 52: 230-6.
30. Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc. 2010; 58: 1299-310.
31. McAlindon TE, Felson DT, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among partecipants in the Framingham Study. Ann Intern Med 1996; 125: 353-9.
32. Glowacki J, Hurwitz S, Thornhill TS, Kelly M, LeBoff MS. Osteoporosis and vitamin D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg 2003; 85: 2371-7.
33. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-7.
34. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-5.
35. Grant WB, Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004; 48: 115-23.
36. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80: 1678S-88S.
37. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362-71.
38. Holick MF. Clinical efficacy of 1,25- dihydroxyvitamin D3 and analogues in the treatment of psoriasis. Retinoids 1998; 14: 12-7.
39. Guyton KZ, Kensler YW, Posner GH. Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol 2001; 41: 421-42.
40. Li Y, Kong J, Wei M, Chen ZF, Liu S, Cao LP. 1,25- dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-38.
41. Hypponen E, Laara E, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-3.
42. Binkley N, Krueger DC, Morgan S, Wiebe D. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin Chim Acta 2010; 14: 1976-82.
43. Heaney RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004; 80 (Suppl.) 1706S-9S.
44. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-43.
45. Durazo-Arvizu RA, Dawson-Hughes B, Sempos CT, Yetley EA, Looker AC, Cao G, et al. Three-phase model harmonizes estimates of the maximal suppression of parathyroid hormone by 25-hydroxyvitamin D in persons 65 years of age and older. J Nutr 2010; 140: 595-9.
46. Adami S, Viapiana O, Gatti D, Idolazzi L, Rossini M. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 2008; 42: 267-70.
47. Carnevale V, Nieddu L, Romagnoli E, Battista C, Mascia ML, Chiodini I, et al. Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects. Bone 2010; 47: 626-30.
48. Bischoff- Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004; 116: 634-9.
49. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, Orav JE, Li R, Spiegelman D, et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 2009; 24: 935-42.
50. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-28.
51. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, Editors; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. ISBN: 0-309- 16395-1, 482 pages. National Academics Press 2010.
52. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010; 25: 305-12.
53. Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005; 53: 1881-8.
54. Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, et al; RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-8.
55. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, et al; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002; 23: 560-9.
56. Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005; 330: 1003-9.
57. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469-72.
58. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999; 281: 1505-11.
59. Nuti R, Martini G, Valenti R, Gambera D, Gennari L, Salvadori S, et al. Vitamin D status and bone turnover in women with acute hip fracture. Clin Orthop Relat Res 2004; 422: 208-13.
60. Melhus H, Snellman G, Gedeborg R, Byberg L, Berglund L, Mallmin H, et al. Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab 2010; 95: 2637-45.
61. Lips P, Obrant KJ. The pathogenesis and treatment of hip fractures. Osteoporos Int 1991: 1: 218-31.
62. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008; 49: 242-50.
63. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res 2008; 23: 143-50.
64. van Schoor NM, Visser M, Pluijm SM, Kuchuk N, Smit JH, Lips P. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 2008; 42: 260-6.
65. Cauley JA, Parimi N, Ensrud KE, Bauer DC, Cawthon PM, Cummings SR, et al; Osteoporotic Fractures in Men (MrOS) Research Group. Serum 25 hydroxyvitamin D and the risk of hip and non-spine fractures in older men. J Bone Miner Res 2010; 25: 545-53.
66. Heaney RP, Holick MF. Why the IOM recommendations for Vitamin D are deficient. J Bone Miner Res 2011; 26: 455-57.
67. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551-61.
68. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005; 294: 2336-41.
69. Ebeling PR, Sandgren ME, Di Magno EP, Lane AW, De Luca HF, Riggs BL. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25- dihydroxyvitamin D3 and intestinal vitamin D receptor concentration in normal women. J Clin Endocrinol Metab 1992; 75: 176-82.
70. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 1981; 305: 372-4.
71. Riggs BL, Hamstra A, De Luca HF. Assessment of 25 hydroxyvitamin D 1α-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract. J Clin Endocrinol Metab 1981; 53: 833-5.
72. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 2003; 14: 577-82.
73. Rossini M, Mattarei A, Braga V, Viapiana O, Zambarda C, Benini C, et al. Risk factors for hip fracture in elderly persons. Reumatismo. 2010; 62: 273-82.
74. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
75. Bilke DD. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 2010; 21: 375-84.
76. Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab 2010; 95: 2630-3.
77. Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 2011; 96: E436-46.
78. Rossini M, Perbellini S, Lazzarin M, Adami S, Bertoldo F, Lo Cascio V. Incidenza di ipovitaminosi D nel Nord Italia. It J Min Elect Metab 1990; 4: 13-7.
79. Van der Wielen RPJ, Lowik MRH, Van den Berg H, De Groot LCPGM, Haller J, Moreiras O, et al. Serum vitamin D concentrations among elderly people in Europe The Lancet, 1995; 345: 207-10.
80. Bettica P, Bevilacqua M, Vago T, Norbiato G. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int 1999; 9: 226-9.
81. Carnevale V, Modoni S, Pileri M, Di Giorgio A, Chiodini I, Minisola S, et al. Longitudinal evaluation of vitamin D status in healthy subjects from southern Italy: seasonal and gender differences. Osteoporos Int 2001; 12: 1026-30.
82. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212-21.
83. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr 1999; 81: 133-7.
84. Giusti A, Barone A, Razzano M, Pizzonia M, Oliveri M, Palummeri E, et al. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006; 29: 809-13.
85. Passeri G, Pini G, Troiano L, Vescovini R, Sansoni P, Passeri M, et al. Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003; 88: 5109-15.
86. Muscarella S, Filabozzi P, D'Amico G, Mascia ML, Annese MA, Scillitani A, et al. Vitamin D status in inpatients admitted to an internal medicine department. Horm Res 2006; 66: 216-20.
87. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res. 2009; 24: 693-701.
88. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-42.
89. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-2.
90. Rossini M, Alberti V, Flor L, Masiero L, Giannini S, Gatti D, et al. Effect of oral vitamin D2 yearly bolus on hip fracture risk in elderly women: a community primary prevention study. Aging Clin Exp Res 2004; 16: 432-6.
91. Giusti A, Barone A, Razzano M, Oliveri M, Pizzonia M, Palummeri E, et al. Persistence with calcium and vitamin D in elderly patients after hip fracture. J Bone Miner Metab 2009; 27: 95-100.
92. Carnevale V, Nieddu L, Romagnoli E, Bona E, Piemonte S, Scillitani A, et al. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int 2006; 17: 478-83.
93. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, et al; ICARO Study Group. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res 2006; 21: 1565-70.
94. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Silvestri S, et al; ICARO Study Group. Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. Osteoporos Int 2008; 19: 1219-23.
95. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, et al. Vitamin D status and response to treatment in postmenopausal osteoporosis. Osteoporos Int 2009; 20: 239-44.
96. Adami S, Bertoldo F, Braga V, Fracassi E, Gatti D, Gandolini G, et al. 25-hydroxy vitamin D levels in healthy premenopausal women: association with bone turnover markers and bone mineral density. Bone 2009; 45: 423-6.
97. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-10.
98. Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, et al. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc. 2010; 58: 1489-95.
99. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3.
100. Harris SS, Dawson-Hughes B. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr 1998; 17: 282-4.
101. Harris SS, Dawson-Hughes B. Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr 2002; 21: 357-62.
102. Boonen S, Lips P, Bouillon R, Bischoff- Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007; 92: 1415-23.
103. Premaor MO, Scalco R, da Silva MJ, Froehlich PE, Furlanetto TW. The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab 2008; 26: 603-8.
104. Leidig-Bruckner G, Roth HJ, Bruckner T, Lorenz A, Raue F, Frank-Raue K. Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels-an observational study during clinical practice conditions. Osteoporos Int 2011; 22: 231-40.
105. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010; 21: 1121-32.
106. Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Ster Biochem Mol Bio 2004; 89-90: 575-9.
107. Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, et al. Estimation of total usual calcium and vitamin D intake in the United States. J Nutr 2010; 140: 817-22.
108. Calvo MS, Whiting SJ. Determinants of vitamin D intake. From: Nutrition and Health: vitamin D. Holick MF ed. Springer Science+ Business Media, LLC 2010.
109. Whiting SJ, Green TJ, Calvo MS. Vitamin D intakes in North America and Asia-Pacific countries are not sufficient to prevent vitamin D insufficiency. J Steroid Biochem Mol Biol 2007; 103: 626-30.
110. Rossini M, Viapiana O, Gatti D, James G, Girardello S, Adami S. La correzione dell'ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. Minerva Med 2005; 96 (Suppl 1): 1-7.
111. Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 2008; 19: 663-71.
112. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-22.
113. Gartner LM, Greer FR; Section on Breastfeeding and Committee on Nutrition. American Academy of Pediatrics. Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics 2003; 111: 908-10.
114. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine, National Academy of Sciences. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press 2000.
115. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009; 20: 1407-15.
116. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008; 93: 3015-20.
117. Heaney RP, Recker RR, Grote J, Horst RL, Armas LAG. Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrinol Metab 2011; 96: E447-52.
118. Ilahi M, Armas LAG, Heaney RP. Pharmacokinetics of a single, large dose of vitamin D3. Am J Clin Nutr 2008; 87: 688-91.
119. Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V, et al. Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 2010; 95: 4771-7.
120. Hollis BW, Wagner CL. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 2004; 80 (Suppl): 1752S- 8S.
121. Federal Food, Drug, and Cosmetic Act of 1980. 21 USC §321.
122. Antia AU, Wiltse HE, Rowe RD, Pitt EL, Levin S, Ottesen OE, et al. Pathogenesis of the supravalvular aortic stenosis syndrome. J Pediatr 1967; 71: 431-41.
123. Seelig M. Vitamin D and cardiovascular, renal and brain damage in infancy and childhood. Ann N Y Acad Sci 1969; 147: 537-82.
124. Aravena T, Castillo S, Carrasco X, Mena I, López J, Rojas JP, et al. Williams syndrome: clinical, cytogenetic, neurophysiological and neuroanatomic study. Rev Med Child 2002; 130: 631-7.
125. Specker B. Vitamin D requirements during pregnancy. Am J Clin Nutr 2004; 80 (6 suppl): 1740S-7S.
126. Rosen CJ. Vitamin D insufficiency. N Engl J Med 2011; 364: 248-54.